FDA Authorizes Emergency Use for Monoclonal Antibody Drug Amid $720 Million Deal

Contact Your Elected Officials
The Epoch Times Header

The Food and Drug Administration (FDA) on Friday announced it handed down an emergency use authorization for Eli Lilly and Company’s bebtelovimab, a monoclonal antibody treatment for COVID-19.

The drug is intended for the treatment of mild to moderate COVID-19, the illness caused by the CCP (Chinese Communist Party) virus in patients aged 12 and older who tested positive for COVID-19 and are “at high risk for progression to severe” disease, including hospitalization or death.

It also applies to individuals for which “alternative COVID-19 treatment options approved or authorized by the FDA are not accessible or clinically appropriate,” according to an FDA news release.

“Bebtelovimab is not authorized for patients who are hospitalized due to COVID-19 or require oxygen therapy due to COVID-19,” said the federal drug regulator. “Treatment with bebtelovimab has not been studied in patients hospitalized due to COVID-19. Monoclonal antibodies, such as bebtelovimab, may be associated with worse clinical outcomes when administered to hospitalized patients with COVID-19 requiring high flow oxygen or mechanical ventilation.”

The agency and Eli Lilly said that bebtelovimab works by binding with the CCP virus spike protein that causes COVID-19 and is similar to other monoclonal antibodies that have been approved by the FDA and other drug regulators.

Meanwhile, the drug also appears to work against the Omicron subvariant BA.2, which some researchers have said is more contagious than the initial strain, according to the agency.

COVID-19-related hospitalizations and deaths through day 29 for those who received bebtelovimab alone or with other monoclonal antibodies were lower than the placebo rate in previous trials of the drug, the FDA and Eli Lilly said.

“Today’s action makes available another monoclonal antibody that shows activity against omicron, at a time when we are seeking to further increase supply,” said Patrizia Cavazzoni, M.D, director of the FDA’s Center for Drug Evaluation and Research, in the release. “This authorization is an important step in meeting the need for more tools to treat patients as new variants of the virus continue to emerge.”

Eli Lilly, in a statement released on Feb. 10, announced that it came to an agreement with the federal government to supply 600,000 doses of the drug for $720 million.

“The supply agreement calls for the delivery of up to 600,000 doses no later than March 31, 2022 with an option of 500,000 additional doses no later than July 31, 2022,” according to the company.

The FDA said that potential side effects include itching, rash, nausea, vomiting, and infusion-related reactions.

By Jack Phillips

Read Original Article on TheEpochTimes.com

The Epoch Times
The Epoch Timeshttps://www.theepochtimes.com/
Tired of biased news? The Epoch Times is truthful, factual news that other media outlets don't report. No spin. No agenda. Just honest journalism like it used to be.

Privilege Is Financial, Not Racial

If we stay divided by race, we’ll keep fighting each other while the true elites of all races thrive unseen, counting their wealth in comfort.

California Repeats Illinois’ History, PROSECUTE Newsom!

California may have improperly licensed 62,000 illegal aliens as Commercial Driver’s License (CDL) truck drivers.

The Stage Is Set For A US-Instigated Security Dilemma Between The Eurasian Rimland & Heartland

The US sends mixed signals on the Sino-Russo alliance after Trump downplayed concerns while Hegseth said he was ordered to “re-establish deterrence.”

Chambers of Horror

Using a shutdown to legislate is like using a flame thrower to light a candle, it provides light momentarily but destroys everything in its path.

Government Shutdown, Health Care, Tax Breaks=Perfect Storm

The shutdown over cuts to health subsidies for the poor stems from Trump’s OBBB plan, which critics say funneled trillions to the wealthy.

About 80 Missing Children Rescued, 1,700 People Arrested in Memphis: Bondi

U.S. Attorney General Pam Bondi said federal operations in Memphis this month recovered 80 missing children and arrested 1,700 people, including 126 gang members.

San Jose Proclaims ‘Republic of China Day,’ Honors Taiwanese Community’s Contributions

San Jose declared Oct. 25 “Republic of China Day,” honoring the Taiwanese American community’s cultural and economic contributions to the city.

US Tightens Ban on Chinese Tech Gears

The United States has extended its ban on Chinese electronics to cover products partly made by companies blacklisted on national security grounds.

FDA Says It’s Eliminating Requirements for Generic Versions of Expensive Drugs

The Food and Drug Administration in draft guidance said it will reduce instances where large human trials are required for biosimilars.

US, South Korea Finalize Trade Deal Reducing Tariffs, Boosting American Investment

The U.S. and South Korea finalized a major trade deal on Oct. 29 as President Trump wrapped up the final hours of his Asian tour on the Korean Peninsula.

Trump, Japanese PM Sign Critical Minerals, Rare Earths Deal

The U.S. president visited Tokyo on the second leg...

Trump Hikes Canada’s Tariffs by 10 Percent for Not Pulling Anti-Tariff Ad Immediately

Trump announced he will increase tariffs on Canada by 10% after ad by provincial government of Ontario misrepresented President Reagan’s speech on tariffs.

Trump Rolls Back Emissions Rules on Copper Smelters

President Trump issued a proclamation aimed at reversing a Biden-era environmental rule that enforced stricter air emission standards on copper smelters.
spot_img

Related Articles

Popular Categories

MAGA Business Central